Eli Lilly and Incyte's Olumiant Helps Eczema Patients in a Late-Stage Clinical TrialThe Motley Fool • 01/27/20
Incyte Stock Pummeled As Late-Stage Failure Casts Doubt On PipelineInvestors Business Daily • 01/03/20
Leading Biotech Stock Crashes After Promising Drug Fails Late-Stage TestInvestors Business Daily • 01/02/20